JP2020526582A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020526582A5 JP2020526582A5 JP2020521495A JP2020521495A JP2020526582A5 JP 2020526582 A5 JP2020526582 A5 JP 2020526582A5 JP 2020521495 A JP2020521495 A JP 2020521495A JP 2020521495 A JP2020521495 A JP 2020521495A JP 2020526582 A5 JP2020526582 A5 JP 2020526582A5
- Authority
- JP
- Japan
- Prior art keywords
- lactobacillus
- composition
- species
- patient
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000186660 Lactobacillus Species 0.000 claims description 23
- 230000003115 biocidal effect Effects 0.000 claims description 9
- 210000001161 mammalian embryo Anatomy 0.000 claims description 8
- 230000002159 abnormal effect Effects 0.000 claims description 7
- 241000218492 Lactobacillus crispatus Species 0.000 claims description 5
- 241000207201 Gardnerella vaginalis Species 0.000 claims description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 4
- 241000186606 Lactobacillus gasseri Species 0.000 claims description 4
- 229940039696 lactobacillus Drugs 0.000 claims description 4
- 241000894007 species Species 0.000 claims description 4
- 241001633064 Atopobium vaginae Species 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 claims description 3
- 208000004926 Bacterial Vaginosis Diseases 0.000 claims description 3
- 230000035935 pregnancy Effects 0.000 claims description 3
- 239000003242 anti bacterial agent Substances 0.000 claims description 2
- 229960002227 clindamycin Drugs 0.000 claims description 2
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 claims description 2
- 238000001514 detection method Methods 0.000 claims description 2
- 230000001605 fetal effect Effects 0.000 claims description 2
- 229960000282 metronidazole Drugs 0.000 claims description 2
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 claims description 2
- 238000002604 ultrasonography Methods 0.000 claims description 2
- 241001561398 Lactobacillus jensenii Species 0.000 claims 1
- 210000002257 embryonic structure Anatomy 0.000 claims 1
- 230000009027 insemination Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 238000000034 method Methods 0.000 description 18
- 208000037009 Vaginitis bacterial Diseases 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 210000002458 fetal heart Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762529733P | 2017-07-07 | 2017-07-07 | |
| US62/529,733 | 2017-07-07 | ||
| PCT/US2018/040882 WO2019010281A1 (en) | 2017-07-07 | 2018-07-05 | USE OF VAGINAL LACTOBACILLES TO IMPROVE IN VITRO FERTILIZATION RATE OF SUCCESS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020526582A JP2020526582A (ja) | 2020-08-31 |
| JP2020526582A5 true JP2020526582A5 (https=) | 2021-07-29 |
Family
ID=64951221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020521495A Pending JP2020526582A (ja) | 2017-07-07 | 2018-07-05 | 体外受精の成功率を向上させるための膣ラクトバチルスの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11278581B2 (https=) |
| EP (1) | EP3648779A4 (https=) |
| JP (1) | JP2020526582A (https=) |
| CN (1) | CN110831610A (https=) |
| AU (1) | AU2018298116A1 (https=) |
| CA (1) | CA3068974A1 (https=) |
| WO (1) | WO2019010281A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3648779A4 (en) * | 2017-07-07 | 2021-03-17 | Osel, Inc. | USING VAGINAL LACTOBACILLI TO IMPROVE THE SUCCESS RATE OF IN VITRO FERTILIZATION |
| EP4294417A1 (en) * | 2021-02-19 | 2023-12-27 | Imperial College Innovations Limited | Lactobacillus crispatus composition for use in pregnant subjects |
| CN115181711B (zh) * | 2022-09-14 | 2022-12-13 | 中国农业科学院北京畜牧兽医研究所 | 人乳杆菌lhm11及菌剂和应用 |
| CN116804176B (zh) * | 2023-06-14 | 2024-07-02 | 善恩康生物科技（苏州）有限公司 | 一株阴道卷曲乳酸杆菌及其在制备防治慢性子宫内膜炎和由ce引起的女性不孕症的药物中的应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6093394A (en) * | 1997-04-11 | 2000-07-25 | Gynelogix, Inc. | Vaginal lactobacillus medicant |
| CN1304313A (zh) * | 1998-06-05 | 2001-07-18 | 若素制药株式会社 | 含乳酸菌的组合物、药物和食物 |
| MX2009000053A (es) * | 2006-07-12 | 2009-02-23 | Controlled Therapeutics Sct | Polimero para el suministro de medicamentos con sal clorhidrato de clindamicina. |
| US20110066137A1 (en) * | 2007-12-18 | 2011-03-17 | Osel, Inc. | Applicator for applying powder formulations and uses thereof |
| US8329447B2 (en) * | 2008-12-12 | 2012-12-11 | Osel, Inc. | Strain of Lactobacillus crispatus |
| CN103911306B (zh) * | 2013-01-05 | 2016-08-24 | 欣力菲生物医药技术（天津）有限公司 | 加氏乳杆菌菌株及其用途 |
| SG11201603346VA (en) * | 2013-11-08 | 2016-05-30 | Suzhou Osel Bio Pharm Co Ltd | Lactobacillus crispatus and application thereof |
| CN104178437B (zh) * | 2013-11-08 | 2016-08-24 | 苏州欧赛微科生物医药科技有限公司 | 一种卷曲乳杆菌及其在妇科疾病中的应用 |
| US10398742B2 (en) * | 2014-12-15 | 2019-09-03 | The Johns Hopkins University | CVS transplantation for treatment of bacterial vaginosis |
| WO2018045359A1 (en) * | 2016-09-02 | 2018-03-08 | Karius, Inc. | Detection and treatment of infection during pregnancy |
| EP3648779A4 (en) * | 2017-07-07 | 2021-03-17 | Osel, Inc. | USING VAGINAL LACTOBACILLI TO IMPROVE THE SUCCESS RATE OF IN VITRO FERTILIZATION |
| WO2019010282A1 (en) * | 2017-07-07 | 2019-01-10 | Osel, Inc. | STABILIZED FORMULATIONS WITH HIGH POWER OF LACTOBACILLUS VAGINAL |
| US10918663B2 (en) * | 2018-04-03 | 2021-02-16 | Reoxcyn, Llc | Compositions and methods for the treatment of bacterial vaginosis |
| JP7445980B2 (ja) * | 2018-05-22 | 2024-03-08 | アートプレッド ビー． ブイ． | 生殖補助医療手法の転帰の予測方法およびキット |
| WO2020007780A1 (en) * | 2018-07-02 | 2020-01-09 | Artpred B.V. | Method and kit for altering the outcome of an assisted reproductive technology procedure |
| EP3843701B1 (en) * | 2018-08-30 | 2024-02-21 | Osel, Inc. | Bacteriocins to improve vaginal colonization of hydrogen peroxide producing lactobacillus for female reproductive health |
-
2018
- 2018-07-05 EP EP18828806.2A patent/EP3648779A4/en not_active Withdrawn
- 2018-07-05 AU AU2018298116A patent/AU2018298116A1/en not_active Abandoned
- 2018-07-05 WO PCT/US2018/040882 patent/WO2019010281A1/en not_active Ceased
- 2018-07-05 CA CA3068974A patent/CA3068974A1/en active Pending
- 2018-07-05 JP JP2020521495A patent/JP2020526582A/ja active Pending
- 2018-07-05 US US16/627,248 patent/US11278581B2/en not_active Expired - Fee Related
- 2018-07-05 CN CN201880045144.5A patent/CN110831610A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Paschkis et al. | Tumor growth in partially hepatectomized rats | |
| JP2020526582A5 (https=) | ||
| US6440949B1 (en) | Method for promoting the growth of gram-positive bacilli and increasing the acidity in vagina | |
| Boudewijns et al. | Rothia dentocariosa, endocarditis and mycotic aneurysms: case report and review of the literature | |
| JP5340941B2 (ja) | 血液、特に末梢血から成体幹細胞を増殖させるための方法及び医療分野におけるその利用 | |
| JP2020526583A5 (https=) | ||
| Vongsariyavanich et al. | Effect of carbetocin administration during the mid-period of parturition on farrowing duration, newborn piglet characteristics, colostrum yield and milk yield in hyperprolific sows | |
| TWI612958B (zh) | 移植器官植活促進劑 | |
| RU2007120570A (ru) | Пероральная дозированная форма кабапептина длительного выделения | |
| JPH09506099A (ja) | 殺ウイルス性、殺菌性および殺精子性膣坐薬 | |
| US11278581B2 (en) | Use of vaginal Lactobacilli for improving the success rate of in vitro fertilization | |
| JPWO2008016039A1 (ja) | 妊娠促進剤 | |
| JP2017512477A (ja) | 治療細菌の小型コロニー変種の調製 | |
| US20090180921A1 (en) | Method of collecting, processing, sterilizing and stabilizing rumen fluid and the contained bacterial polysaccharides | |
| US6964949B2 (en) | Pharmaceutical compositions for promoting the growth of gram-positive bacilli and increasing the acidity in the vagina and the use thereof | |
| US11116801B2 (en) | Composition containing endometrial decidual cells for treating damage to the endometrium or enhancing implantation functions | |
| CN102397271A (zh) | 臭氧油在动物感染类疾病中的应用 | |
| Nordstoga et al. | Vaginal deposition of frozen-thawed semen in Norwegian dairy goats: comparison of single and double insemination with equal total number of spermatozoa | |
| Jeyakumar et al. | Advances in estrous synchronization and timed breeding programs for fertility enhancement in cattle and buffaloes | |
| Nayak et al. | Induction of oestrus in true anestrus buffaloes using Crestar implant alone and in combination with PMSG | |
| CN110101655A (zh) | 一种修复宫颈及预防细菌性阴道炎的组合物 | |
| Zahid et al. | Effect of chloroquine on liver weight of developing albino rats | |
| RU2240781C1 (ru) | Способ лечения воспалительных процессов вульвы и влагалища | |
| KR102017386B1 (ko) | 이식된 지방세포의 생착 증진용 조성물 및 지방 이식용 세포 치료제 조성물 | |
| Bronson et al. | Placental retention in a golden lion tamarin (Leontopithecus rosalia) |